These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 4756820)

  • 1. Drug absorption, metabolism, and excretion. IX. Some new aspects of pharmacokinetics on tolbutamide in rabbits.
    Shibasaki J; Konishi R; Morishita T; Ueki T
    Chem Pharm Bull (Tokyo); 1973 Aug; 21(8):1754-63. PubMed ID: 4756820
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug absorption, metabolism, and excretion. 8. Determination of tolbutamide and its metabolites in blood and urine.
    Shibasaki J; Konishi R; Ueki T; Morishita T
    Chem Pharm Bull (Tokyo); 1973 Aug; 21(8):1747-53. PubMed ID: 4756819
    [No Abstract]   [Full Text] [Related]  

  • 3. Biological studies of the rate of alimentary absorption and urinary excretion of tolbutamide and certain newly synthesized chemically related congeners in rabbits.
    Abdel Wahab MF; El-Allawy RM; Madkour MK
    J Egypt Med Assoc; 1976; 59(3-4):177-90. PubMed ID: 1032142
    [No Abstract]   [Full Text] [Related]  

  • 4. [Relationship between the pharmacokinetic and pharmacodynamic parameters of tolbutamide. II].
    Vila Jato JL; Dominguez-Gil Hurlé A
    Boll Chim Farm; 1978 Apr; 117(4):240-5. PubMed ID: 743372
    [No Abstract]   [Full Text] [Related]  

  • 5. [Biopharmaceutical aspects of butamide tablets].
    Voronina LM; Zykova NIa; Salo DP; Tomas R
    Farm Zh; 1978; (1):87-8. PubMed ID: 631310
    [No Abstract]   [Full Text] [Related]  

  • 6. Tolbutamide-sulfaphenazole interaction in rabbits.
    Shibasaki J; Konishi R; Yamasaki K
    J Pharmacokinet Biopharm; 1977 Jun; 5(3):277-90. PubMed ID: 881646
    [No Abstract]   [Full Text] [Related]  

  • 7. Dissolution behaviors and gastrointestinal absorption of tolbutamide in tolbutamide-polyvinylpyrrolidone coprecipitate.
    Sekikawa H; Naganuma T; Fujiwara J; Nakano M; Arita T
    Chem Pharm Bull (Tokyo); 1979 Jan; 27(1):31-7. PubMed ID: 428030
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of naproxen on glucose metabolism and tolbutamide kinetics and dynamics in maturity onset diabetics.
    Whiting B; Williams RL; Lorenzi M; Varady JC; Robins DS
    Br J Clin Pharmacol; 1981 Mar; 11(3):295-302. PubMed ID: 7213531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship between the pharmacokinetic and pharmacodynamic parameters of tolbutamide. I].
    Vila Jato JL; Dominguez-Gil Hurlé A
    Boll Chim Farm; 1978 Jan; 117(1):47-53. PubMed ID: 743351
    [No Abstract]   [Full Text] [Related]  

  • 10. Interaction of pargyline with tolbutamide in rabbits.
    Satyanarayana S; Krishna DM; Krishnaiah YS; Visweswaram D
    Indian J Physiol Pharmacol; 1995 Jan; 39(1):71-3. PubMed ID: 7705875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic analysis of tolbutamide-sulfonamide interaction in rabbits based on clearance concept. Prediction of species difference from in vitro plasma protein binding and metabolism.
    Sugita O; Sawada Y; Sugiyama Y; Iga T; Hanano M
    Drug Metab Dispos; 1984; 12(1):131-8. PubMed ID: 6141904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of rifampicin on the pharmacokinetics of tolbutamide in healthy subjects].
    Zilly W; Bopp E; Bürkl B; Richter E
    Verh Dtsch Ges Inn Med; 1974; 80():1538-40. PubMed ID: 4454477
    [No Abstract]   [Full Text] [Related]  

  • 13. The metabolism of tolbutamide and cyclamate.
    Glogner P
    Humangenetik; 1970; 9(3):230-2. PubMed ID: 5465541
    [No Abstract]   [Full Text] [Related]  

  • 14. Tolbutamide hydroxylation by human, rabbit and rat liver microsomes and by purified forms of cytochrome P-450.
    Veronese ME; McManus ME; Laupattarakasem P; Miners JO; Birkett DJ
    Drug Metab Dispos; 1990; 18(3):356-61. PubMed ID: 1974199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carboxytolbutamide excretion following subcutaneous implantation of tolbutamide spheres in rats.
    BALLARD BE; NELSON E
    Arch Int Pharmacodyn Ther; 1961; 133():206-11. PubMed ID: 13864429
    [No Abstract]   [Full Text] [Related]  

  • 16. Tolbutamide as a model drug for the study of enzyme induction and enzyme inhibition in the rat.
    Back DJ; Sutcliffe F; Tjia JF
    Br J Pharmacol; 1984 Mar; 81(3):557-62. PubMed ID: 6697063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of tolbutamide after oral administration in rabbits with folate-induced renal failure.
    Bae HY; Choi DH; Choi JS
    Res Commun Mol Pathol Pharmacol; 2002; 111(5-6):237-44. PubMed ID: 15244039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apparent Michaelis constants for the metabolism of (ureyl- 14 C)tolbutamide by human liver microsomal preparations.
    Darby FJ; Grundy RK; Evans DA
    Biochem Pharmacol; 1972 Feb; 21(3):407-14. PubMed ID: 5014495
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of tolbutamide metabolism by substituted imidazole drugs in vivo: evidence for a structure-activity relationship.
    Back DJ; Tjia JF
    Br J Pharmacol; 1985 May; 85(1):121-6. PubMed ID: 4027461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic metabolism of tolbutamide: characterization of the form of cytochrome P-450 involved in methyl hydroxylation and relationship to in vivo disposition.
    Knodell RG; Hall SD; Wilkinson GR; Guengerich FP
    J Pharmacol Exp Ther; 1987 Jun; 241(3):1112-9. PubMed ID: 3598900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.